Mesh ： Adrenergic beta-2 Receptor Agonists / therapeutic use Anti-Bacterial Agents / therapeutic use Bronchodilator Agents / therapeutic use Cholinergic Antagonists / therapeutic use Continuous Positive Airway Pressure Exercise Expectorants / therapeutic use Glucocorticoids / therapeutic use Humans Influenza Vaccines Oximetry Oxygen Inhalation Therapy Patient Education as Topic Phosphodiesterase Inhibitors / therapeutic use Pneumococcal Vaccines Pneumonectomy Pulmonary Disease, Chronic Obstructive / diagnosis epidemiology therapy Radiography, Thoracic Respiratory Function Tests Respiratory Therapy Risk Factors Self Care Social Support Surveys and Questionnaires Tomography, X-Ray Computed Weight Gain alpha 1-Antitrypsin / therapeutic use

来  源：   DOI：10.1159/000346025   PDF(Sci-hub)

Abstract：
The new Swiss Chronic Obstructive Pulmonary Disease (COPD) Guidelines are based on a previous version, which was published 10 years ago. The Swiss Respiratory Society felt the need to update the previous document due to new knowledge and novel therapeutic developments about this prevalent and important disease. The recommendations and statements are based on the available literature, on other national guidelines and, in particular, on the GOLD (Global Initiative for Chronic Obstructive Lung Disease) report. Our aim is to advise pulmonary physicians, general practitioners and other health care workers on the early detection and diagnosis, prevention, best symptomatic control, and avoidance of COPD as well as its complications and deterioration.
摘要：
新的瑞士慢性阻塞性肺疾病（COPD）指南基于以前的版本，10年前出版的。瑞士呼吸学会认为，由于有关这种流行和重要疾病的新知识和新的治疗进展，有必要更新以前的文件。建议和声明基于现有文献，关于其他国家准则和，特别是,关于GOLD（全球慢性阻塞性肺疾病倡议）报告。我们的目的是为肺部医生提供建议，全科医生和其他医护人员的早期发现和诊断，预防,最好的症状控制，避免COPD及其并发症和恶化。
公众号